Innate Immunity and Autoimmune Diseases by Vargas, Marcela Catalina Fandiño
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
125,000 140M
TOP 1%154
5,000
1Chapter
Innate Immunity and 
Autoimmune Diseases
Marcela Catalina Fandiño Vargas
Abstract
The innate immune response is responsible for the initial defense against 
invading pathogens and signs of damage; in turn, it activates the adaptive immune 
response to result in highly specific and lasting immunity, mediated by the clonal 
expansion of antigen-specific B and T lymphocytes. Inflammation is the acute 
response to infection and tissue damage to limit aggression to the body. It is a 
complex reaction of vascularized tissues to infection, toxin exposure or cell injury 
that includes extravasation of plasma proteins and leukocytes. Paradoxically, 
uncontrolled and prolonged inflammation can result in secondary damage and 
the development of immune pathology in the host. The components of the innate 
immune system have recently been studied as responsible mechanisms in various 
chronic diseases such as diabetes mellitus, atherosclerosis, asthma and allergies, 
among others. Autoimmune disease is an attack on auto tissues by the adaptation 
of the immune system. In general, such diseases are characterized by autoantibod-
ies and/or autoreactive lymphocytes directed at antigens against themselves. The 
innate immune system is often considered an effector of self-reactive lymphocytes, 
but also provides protection. Studies in mice with specific gene-directed mutations 
show that defects in innate immune system proteins may predispose to the develop-
ment of a systemic lupus erythematosus-like syndrome (lupus) characterized by 
autoantibodies against double-stranded DNA (ds DNA) or nuclear components. 
This seems to be due to a failure in the removal of apoptotic cells or nuclear waste. 
These observations imply that the innate immune system has a general protective 
role against autoimmune disease. For example, in systemic diseases such as lupus, 
innate immunity is important in the elimination of nuclear antigens and, therefore, 
in the improvement of tolerance to B lymphocytes. Alternatively, in specific organ 
disorders such as type diabetes 1 o Crohn’s disease, the innate immune system can 
be protective by eliminating pathogens that trigger or exacerbate the disease or 
regulate the presentation of antigens for T lymphocytes. Discuss various disease 
models in which the innate immune system could provide a protective role, defi-
ciencies in the regulation of B lymphocyte signaling through the antigen/receptor 
or in the clearance of lupus antigens, (dsDNA and nuclear proteins), can lead to a 
disease similar to lupus. The repertoire of B cells seems to be very biased toward 
self-activity, as, possibly, that of the T-cell. This tendency toward self-activity is not 
surprising because B and T cells are positively selected against highly conserved 
autoantigens.
Keywords: toll, antigens, dendritic cells, lymphocytes, lupus, PAMP, 
DAMP tolerance, autoimmunity
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1. Introduction
The human immune system has two major divisions: innate and acquired. We 
will talk about innate immunity. Innate immunity can be defined as the first line of 
defense against pathogens, which represents a great machinery to create an adequate 
and definitive systemic response to prevent infections and maintain homeostasis 
of the organism. The elements of innate immunity include external physical barri-
ers, humoral and cellular effector mechanisms. This type of immunity recognizes 
pathogens such as bacteria and viruses. This works thanks to the phagocytosis of 
the pathogens with the consequent induction of inflammatory reactions. It also has 
a critical role in the activation and regulation of adaptive immunity. This immunity 
has the ability to develop an induced response during primoinfection. This response 
is specific due to the expression of cell surface pattern recognition (PRR) receptors, 
which are capable of recognizing complex polysaccharides, glycolipids, lipopro-
teins, and nucleic acids. We know that pathogens contain in their structure various 
components that act as substances strange (antigens) and this in turn will induce an 
innate immune response that will subsequently activate the adaptive response. It is 
imperative to recognize that the important exploration of these innate mechanisms 
is essential for the understanding of the complex events involved in human innate 
immunity and is also crucial for the discovery of new antimicrobials, antitumor 
drugs, and immunomodulators with therapeutic applications [1]. Innate immunity, 
which is considered a simple immune system, is essential for the onset of acquired 
immunity and has been found to play an important role in the pathogenesis of the 
disease age [2]. Among them, it recognizes nucleic acids derived from pathogens. 
The innate immune pattern recognition (PRR) receptor recognizes self-derived 
nucleic acids. Innate pattern recognition receptors regulate antigens for the presen-
tation and subsequent responses of B cells and T cells, for example, physiological 
management of autoantigens, induction of immature dendritic cells to detect toler-
ant signals to T cells. The activation of toll-like receptors (TLR), NOD type recep-
tors (NLR) or Helicases similar to RIG (RLH) by molecular agents associated with 
pathogens where the patterns will induce dendritic cell maturation, costimulation.
T cell activation and production of antibodies by B cells. Therefore, recognition 
of innate patterns is now being considered as a central element of immunity modula-
tion. There are at least 80 different autoimmune diseases discovered so far, which in 
the US alone, affect 20 million people [3]. These pathologies are established systemi-
cally or in a specific organ, but require for their expression certain conditions that are 
the result of multifactorial processes that involve a deregulation of the innate immune 
system and therefore adaptive that lead the body to erroneous responses with the 
subsequent attack itself of their own tissues. The innate immune system as discussed 
above is the first line of immediate defense against invading microorganisms that 
links to the adaptive response. Specific cells of the innate immune system, which are 
dendritic cells (DC) (antigen presenting), which are cells with an important and criti-
cal role in promoting the responses of B and T cells. This type of immunity is critical 
to maintain homeostasis and prevent microbial invasion, eliminating a wide variety 
of pathogens and contributing to the activation of the adaptive immune response.
2. The entrance door: PAMP/DAMP
It is the control point. A dendritic type receptor that bears the title of “access 
gate” for innate cellular immunity: this basically consists of a type of toll-like recep-
tor. It has been found that it plays a fundamental role as a sensor in the recognition 
of pathogens in the innate immune system [4].
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3. Let’s talk about PAMP
This pattern recognition receptor acts on bacteria and viruses (PAMP) [5]. 
The innate immune response in immunological terms controls the infection and 
prevents its spread. And more recently it is known that to induce this series of 
reactions against pathogens, in addition to the existence of antigens, another 
series of molecules in the pathogens is required. These molecules are known as 
pathogen-associated molecular patterns (PAMPs). PAMPs play and interact with 
a series of receptors that are mainly present in phagocytic cells (macrophages), 
and these “gate” receptors have been called recognition patterns to pathogen-
associated molecular patterns (PRRs). These receptors contain other subfamilies 
where we can find toll type receptors (TLRs), NOD type receptors (NLRs), RIG-1 
type receptors (RLRs), and lectin C type (CLRs). This molecular pattern related 
to the associated damage known as DAMP comes to behave as a type of alert that 
recognizes signals and most importantly this does not involve pathogen detection. 
The main molecular recognition patterns (PRRs) include TLR and NLR receptors, 
also known as nucleotide binding oligomerization domains. TLR is the homologous 
receptor that has already been identified in the Drosophila genetic code, and that to 
date some TLRs have been found in humans mainly in the cell surface, membrane, 
and lipids [6]. Types 1, 2, 4, 5, and 6 are those that recognize proteins, nucleic acids 
located in the endoplasmic reticulum and those that are found in the endosomal 
membranes. 3, 7, 8, and 9 detect lipopolysaccharides in the outer membrane of 
gram-negative bacteria (endotoxins). The TLR4 type, which transmits inflamma-
tory signals, is the best known in general and the most studied of the TLR. This 
receptor responds to MyD88, which becomes a station at the central point of the 
inflammation signal, and corresponds to the first phase of activation of the tran-
scription factor NF-κB pathway (nuclear factor-kappa B), which a In turn, produc-
tion begins and a kind of “chain reaction” of inflammatory cytokines to eliminate 
pathogens [7]. Meanwhile, these TLR receptors are incorporated into PAMPs, 
which by recognizing nucleic acids act as an inflammatory cytokine. Receptors 
that mediate innate immune responses, such as toll-like receptors (TLR) and 
specific C-type lectin receptors (CLR) that recognize associated molecular patterns 
(PAMP), have been implicated in autoimmune disease mechanisms, both directly 
through self-recognition ligands and indirectly through the regulation of immune 
homeostasis [8, 9].
4. DAMPs: (the antigenic gift of cells)
In intracellular infections, in addition to antigens and PAMPs, the participation 
of another series of molecules that participate in the activation of the immune 
response is necessary. Recently, some studies have shown that cells can die from 
a type of immunogenic “apoptosis” and thus expose their nuclear or cytoplas-
mic molecules to their membrane. These have a way of stimulating the immune 
response, thanks to their activity. They are also released during the process of 
necrosis and have been given the name of molecular patterns associated with dam-
age or warning signs, the famous DAMPs. The NLR receptor is present in the cyto-
plasm. It has the particularity of recognizing not only PAMP but also several DAMP 
among them [uric acid, cholesterol, sterols crystals, extracellular ATP (adenosine 
triphosphate), silica] or even recognizing exogenous DAMP such as asbestos, origin 
of aseptic inflammation, such as gout, arteriosclerosis, and silicosis [10]. It is clear 
that it is a cause and attracts attention. The abnormalities in the immune system 
that are the basis and fertilizer for autoimmune diseases are mainly caused by an 
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abnormal acquired immunity [11]. In recent years, in contrast to the concept that 
autoimmune or auto-inflammatory diseases are mainly due to abnormal innate 
immunity, it is attracting more attention.
5. Innate immunity cells: “soldiers of the first line of defense”
Dendritic cells, macrophages, and other myeloid cells also play an important role 
in the innate immune response, both as antigen presenting cells as effector cells that 
mediate the tissue damage [12–14]. Therefore, they are fundamental and will be as 
in conflicts, “the first line of defense” in the face of a bacterial or other stimulus. 
We will also take them into account in relation to autoimmune diseases, because of 
their responsiveness and because they are important mediators of innate immu-
nity, an interest has arisen in this potential to contribute to the pathology of these 
diseases. Proinflammatory cytokines: mainly TNFa (tumor necrosis factor alpha), 
induce the activation of endothelial cells, resulting in an increase in the expression 
of different adhesion molecules (CD62E, CD62P, ICAM-1, and VCAM-1). This 
causes the leukocytes to roll over them, and during this bearing, they are activated 
by the intracellular signals that are generated through their adhesion molecules and 
different chemokine receptors, which interact with the ligands found on the surface 
of the cells endothelial. Subsequently, these activated leukocytes adhere firmly to 
the endothelium, change their morphology (cell polarization) and carry out their 
transendothelial migration, and then migrate to the inflammatory focus, guided by 
the gradient of chemotactic substances that are released. Macrophages are multi-
functional antigen presenting cells, with an important role in innate immunity and, 
therefore, in the inflammation process [15]. Macrophages are found in almost all 
organs, and recent studies have demonstrated their multifunctionality and hetero-
geneous capacities established by their numerous subpopulations, adaptation in 
specific tissue microenvironments and different stages of maturation. For example, 
during a bacterial infection, classically activated macrophages show inflammatory 
functions (type 1 or M1 macrophages), while with alternative activation (by Th2 
type cytokines, such as IL-4 or IL-13), macrophages acquire anti-inflammatory 
functions (type 2 macrophages or M2). In addition to depletion or inhibition of 
macrophage function, reprogramming of M2 has also been explored. Recently, it 
has been shown that paracoccin, a protein contained in a fungal human pathogen, 
induces the repolarization of M1 macrophages through interaction with toll as a 
receptor (TLR) 4, being a new possible immunotherapeutic agent for pathologies 
related to M2 macrophages. Macrophage-related therapies have been proposed 
for various autoimmune and inflammatory pathologies. In the case of PPARγ and 
PPARδ, which are nuclear receptors that control different genes associated with 
M2 macrophages, and their agonists have been proposed as a therapy directed at 
macrophages to induce M2 pathways. In addition, the demonstration that TLR9 
receptor signaling can reverse the aberrant M2 macrophage phenotype.
Dendritic cells (DC) are professional antigen presenting cells (APC), often 
referred to as “orchestra directors of the innate immune response” due to their 
ability to capture, process, and present antigens to T cells. Depending on the nature 
of the antigen may exhibit an immunogenic or tolerogenic effect, which will be 
defined by cytokine secretion. They are often considered tolerogenic, because 
they have autoantigens in the absence of costimulation and, together with anti-
inflammatory stimuli, (TGF-β), can promote the induction of regulatory T cells 
and/or induce anergy of T cells [16]. After activation by proinflammatory stimuli, 
they mature and generate an expression of costimulatory molecules and the major 
histocompatibility complex (HCM) class II, which causes a potent response of 
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specific T cells to the antigens. Therefore, they play a fundamental role in maintain-
ing self-tolerance, and on the other hand, they initiate the response against foreign 
antigens for their subsequent elimination by effector immune cells. In a state of 
aberrant hyperreactivity, they could contribute to perpetuating immune responses, 
backed by evidence of a high frequency of immunogenic infiltration [17]. Due to 
their ability to modulate the cellular response, they have been considered a power-
ful target for immune modulation. Strategies such as pharmacological modulation 
to affect their maturation status and genetic engineering to improve their toler-
ance or immunogenic properties for the treatment of autoimmune diseases have 
been studied. In several murine models, they were transduced to express IL-4 and 
were able to prevent disease in 12-week NOD mice. In a murine model of collagen-
induced arthritis (CIA), it was shown that the injection of dendritic cells with 
tolerogenic activity improves the clinical and the outcome of the disease. Although 
the treatment was found to be safe and feasible, other studies are needed to evaluate 
the efficacy of cellular treatment in autoimmunity.
6. Innate lymphoid cells (ILC): “the element of surprise”
They are a growing family of immune cells that reflect the phenotypes and 
functions of T cells. Natural killer cells (NK) can be considered innate homologs of 
cytotoxic CD8 + T cells, while ILC1, ILC2, and ILC3 correspond to innate homologs 
of T cells CD4 + (TH1), TH2, and TH17. However, in contrast to T cells, they do not 
express antigen receptors or undergo clonal selection and expansion when stimu-
lated [4]. The ILCs react and respond to the signs of tissue damage and produce a 
series of cytokines, which direct the immune response and this adapts to contain 
the lesion. Therefore, these cells can control or unleash the immune response. As 
with B cells and T cells, these also originate from the common lymphoid lineage 
but the specific transcription factors of these suppress and modify their develop-
ment until the generation of the different types of ILC. The precursors of these can 
migrate from their primary production site in infected and injured tissues, where 
they complete their maturation, in a process very similar to the differentiation of 
virgin T cells into TH effectors. The cytokines produced by local cells, as well as 
some trauma and stress response ligands as well as bacterial and dietary compounds 
regulate the maturation and activation of ILC in effectors that play an important 
role in early immune responses to pathogens in particular has been found relation-
ship with symbionts, helminths, and allergens. The cytokines they produce induce 
innate responses in stromal, epithelial, and myeloid cells that in turn will regulate 
the activity of dendritic cells and will also play a central role in the transfer of infor-
mation between ILC and T cells. ILCs by activating DC found in tissues to migrate 
to the lymph nodes, where they cause specific T-type cellular responses. ILCs also 
regulate T cells directly through the presentation of peptide antigens through CMH 
type II. However, ILCs are also involved in autoimmunity, because their cytokine 
production can exacerbate and exaggerate the inflammatory process.
7.  The eye of the hurricane: autoimmunity and innate immune system. 
How can an autoimmune disease use machinery of innate immunity?
Recent research has revealed new knowledge about the respective roles of these 
cells in relation to cellular and humoral immunity as well as the extension to adap-
tive immunity [18]. There is talk of a recent study in which a genetically modified 
mouse prototype model was developed with an autoimmune disease similar to lupus 
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that does not require to express the adaptive immune system machinery, but is trig-
gered directly by the innate immune response [19]. For many autoimmune diseases, 
we largely know the roles that key cells (T cells and B cells) play and for example 
are evident in the success of existing therapies (anti-CD3 and anti-CD20). Then 
knowing this, each of the functions of myeloid cells, and in general of the innate 
immune response cells, can “autoimmune” disease occur in the absence of adaptive 
immunity and these cells act as effectors in disease progression? The answer to this 
could be yes [20]. The most recent example is the study of mice eaten by moths that 
have been genetically modified to have deficiencies in hematopoietic cells, and to 
express an autoimmune disease characterized by alopecia (giving a “peeled or eaten 
by moths”) and edema in their legs. These were also accompanied by high antibody 
titers, with renal and pulmonary functions being compromised due to immune 
complex deposits [21, 22]. However, in another study, mice with deficiency in 
hematopoietic cell phosphatase were crossed with mice that lack the recombinase-1 
activator gene (RAG-1) that caused a subsequent deficiency in the production of T 
and B cells and found that the disease autoimmune had progressed normally in the 
absence of an adaptive immune response [22, 23] even though these mice lacked 
high antibody titers and immune complex deposits, and they exhibited all other 
symptoms of the disease. Subsequently, although the onset and progression of the 
disease could not be defined, it was concluded that the autoimmune disease of this 
type of mice was mediated by an aggressive response of macrophages and other 
myeloid cells. Now, a study with murine models is also described, with mice with 
a genetic alteration associated with the deficiency in the enzyme α-mannosidase 
type II (αM-II) where there is premature aging with the clinical expression and 
the characteristic symptoms of SLE and Lupus nephritis (high titers of anti-DNA 
antibodies, glomerulonephritis, and renal compromise due to deposition of immu-
noglobulins in the kidney) that seems to be driven by a mechanism that also seems 
to involve the innate immune system [12, 24, 25]. In the case of the murine model, 
evidence was provided that the abnormal presence of hybrid glycoprotein struc-
tures acts as a trigger for the induction of an innate immune response mediated by 
members of the C-type lectin family that is specific for mannose. Serum mannose-
binding lectins (MBL-A and MBL-B) are soluble lectins that mediate innate immu-
nity to pathogenic bacteria and fungi that express glucans (mannose). It is also 
believed that the macrophage of the mannose receptor cell surface (MMR) par-
ticipates in innate immune responses, and its expression has been documented in 
mesangial renal cells [26, 27]. In mice with αM-II deficiency, MBL lectins are depos-
ited in renal glomeruli which, when they express high levels of mannose glucans in 
mesangial cells, also express higher levels of MMR, which can bind mannose ligands 
in the serum. Monocyte chemoattractant protein 1 (MCP-1) levels, produced by 
activated mesangial cells, represent the entry of activated macrophages. By aber-
rantly expressing mannose-containing glucans in mice with αMII deficiency, they 
act as triggers for an innate immune response mediated by mannose-specific C-type 
lectins programmed to recognize mannose glucans as PAMP.
The second point in importance is the role of antibodies in stimulating the 
innate immune response. How can this be to the production of autoantibodies in 
autoimmune diseases, such as our old friend, lupus? Systemic lupus erythematosus 
(SLE) is an autoimmune disease that translates inflammation and exaggerated 
immune responses and thus with a large generalized associated tissue damage. We 
are clear that innate immunity plays a great role in its development and sequen-
tially its clinical expression, and it has been shown that defects found in any of the 
immune recognition pathways will promote autoimmunity. First, dendritic cells and 
macrophages activated by TLR receptors can regulate the differentiation of self-
reactive B cells through the expression of CD40 and the action of IL-6. Second, by 
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nucleic acids. These can activate and in a powerful and disorderly way certain TLR 
and RLH receptors; therefore, these are normally protected from immune recogni-
tion by multiple mechanisms (epigenetic modifications, nuclear compartmentaliza-
tion, and the rapid elimination of cells that have entered apoptosis and extracellular 
compartments by a type of DNase and RNAse enzymes). These immune complexes 
containing chromatin or circulating RNA particles can avoid being “digested” by 
these enzymes in the extracellular space and facilitate the uptake of the complex 
in intracellular compartments through Fc receptor-mediated endocytosis (FcR) in 
dendritic cell-mediated uptake or by B cell receptor (BCR) in B cells. And it has also 
been confirmed by studies with lupus-prone mice deficient in TLR receptors and 
their respective signaling molecules. As an exception, mice with TLR-9 deficiency 
with a predisposition to lupus produce more autoantibodies against it, indicating 
that TLR-9s have additional functions in the regulation of systemic autoimmunity. 
Innate pattern recognition (PRR) receptors regulate the production of autoantibod-
ies associated with lupus and self-reactive T cells by modulating the presentation 
of autoantigens and also contribute directly to the end result that is tissue or organ 
injury secondary to autoimmunity. In general, it is believed that this “injury” or 
tissue damage is generated from the deposition of the immune complex, comple-
ment activation, and subsequent release of cytokines and chemokines to trigger 
local inflammation. This concept has been redefined. For example in glomerulone-
phritis, in the glomerular immune complex, deposits are not always associated with 
innate and adaptive immune responses. These are traditionally seen as separated 
from each other, but emerging evidence suggests that they overlap and interact 
with each other. Recently discovered cell types, particularly innate lymphoid cells 
and myeloid cell-derived suppressors that are gaining increasing attention. It is a 
rapidly evolving field with molecular pathways and new types of discovered cells 
and multiple constantly changing paradigms. In general, it is believed that many 
autoimmune diseases are triggered by aggressive responses of adaptive immunity by 
an automatic antigen system, resulting in tissue damage and pathological sequelae.
The third point is undoubtedly the role of infectious agents, which have the 
potential to trigger an exaggerated immune response, through molecular imitation, 
polyclonal activation or antigen release. For example, there are certain diseases 
that respond to certain infectious autoantigen peptides. This is the case of multiple 
sclerosis, where T cells are activated by Epstein-Barr virus peptides, type A flu, 
and human papilloma and that react with the myelin autoantigen peptide [28]. 
In this case, the viral infection could cause the activation of the lymphocytes, 
and the autoantigen could maintain this activation, even after the eradication of 
the infectious agent. Microbial infection can also cause polyclonal activation of 
lymphocytes, and this is the underlying mechanism in increasing the incidence 
of autoimmunity in murine models exposed to microbial pathogens [29]. Microbes 
(viruses or bacteria) that destroy cells also cause an inflammatory response and 
also the release of antigens that have been previously captured and this could also 
result in autoimmunity. There is another important point. Inflammation, even in 
the absence of infection, can trigger polyclonal activation and self-activity. This 
is that through the activation of annergic cells, by inflammatory mediators or the 
activation of new self-reactive cells in an inflammatory environment for example 
in the context of ischemia of any tissue, tissue autoreactivity could be caused and 
because not at a systematic level [3]. Within non-infectious detonators, we have 
those of the hormonal type that in many autoimmune diseases are more common in 
women than in men. Drugs can also alter the immune repertoire. One of the most 
common and studied procainamide induces antinuclear antibodies and sometimes 
induces a lupus-like syndrome. And even some substances produced by the same 
cells can act as haptens and make autoantigens immunogenic, for example, CD1 T 
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cells, with receptors (gamma/delta), CD4+, CD25+, and cytokine-producing agents 
that monitor activity, reduce, and control self-reactive cells, and they can become 
pathogenic. As some must complete their maturation in the thymus, and others 
the activation of autoantigens in the periphery, in these processes alterations in the 
number and function of regulatory cells that can contribute to autoimmunization 
can be generated.
8. “War”: mechanisms of tissue damage of innate immunity
Upon contact with the stimulus, whether microbial or of any substance, the 
recruitment and activation of macrophages will begin. The macrophages will serve 
as the primary effector cells that cause tissue damage and loss. And it has been 
concluded that the vast majority of autoimmune diseases could be explained by 
an aberrant adaptation as an immune response to the antigens themselves. On the 
other hand, autoimmunity as a disease contrasts with innate immunity. The first 
in which the term autoinflammatory was used was the periodic fever syndrome 
related to the TNF receptor (tumor necrosis factor), whose causative gene is TRAPS 
4 and which was directly related to the presence of genetic abnormalities associated 
with innate immunity autoinflammatory diseases that are generally considered as 
a group of diseases where we can find an active responsibility for aberrant innate 
immunity and in which T cells are not detected and include TRAPS, cryopyrine-
associated syndrome (secondary to mutations in the NLRP3 gene in children) 
(CAPS), Familial Mediterranean Fever (FMF), Bechet’s disease, Still’s disease in 
adults, Crohn’s disease, Gout, Type 2 diabetes, and various metabolic disorders 
[30]. The mechanism of its many initiation is still unclear, but the symptoms and 
diseases themselves are caused by the collapse of immune tolerance. Thymus 
autoreactivity and subsequent and completely abnormal inactivation of recep-
tive and regulatory (Th) T cells suppress the reaction to the foreign antigen. The 
other part of the aberrant response of the innate immune response is carried out in 
the recipients of recognition of autoimmune patterns and diseases recognized by 
nucleic acids (PRR). This recognition is transmembrane due to its location in the 
cell and is divided into two general and cytoplasmic phases. This receptor is found 
in the endoplasmic reticulum or endosome and is directly related to autoimmune 
diseases (SLE = TLR7/9). When comparing the sequence of own nucleic acids 
and pathogen derivatives by means of the TLR7/9TLR9 receptors, it is noted that 
it contains unmethylated CpG sequences, and these are derived from pathogens 
that in turn recognize a type of single stranded DNA. TLR7 on the other hand 
recognizes single stranded RNA derived from viruses and other types, as well as 
messenger RNA (mRNA). From this, TLR7/9 is self-sufficient, and this receptor can 
strictly distinguish between conventional nucleic acids and pathogen derivatives. 
Stimulates an immune response in response to auto-nucleic acid. In other words, 
viruses and infected cells are captured by endosomes, and these nucleic acids are 
recognized by TLR7/9. In the case of SLE, the TLR7/9 receptor, due to the genetic 
modification secondary to the aberrant response to the own nucleic acids that 
were released and transferred to the endosome and therefore increases the genetic 
expression of the type I IFN and is known as the “IFN signature.” This signature 
of IFN is directly related to SLE, rheumatoid arthritis (RA), and systemic sclerosis 
(SSc) and its effects, suggesting the importance of type I IFN in autoimmune 
disease [31]. It also activates and stimulates plasma cells that in turn produce large 
amounts of type I IFN.
The TLR7/9 receptor also mediates the response of plasmacytoid cells and is 
considered an IFN type I producing cell, which through the TLR7/9 Fc receptor 
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activates the signal to induce the production of non-protein IFN type I histone in 
the core (HMGB1), to subsequently activate DAMP. The balance between TLR7 
and TLR9 is also considered important for inflammation and immune response. 
The other transmembrane PRR receptors TLR3 and TLR8 also recognize double 
stranded and single stranded RNA. On the other hand, the cytoplasmic PRR 
receptor, type RIG-I, and MDA-5 normally identifies a specific structure of single 
stranded RNA. By recognizing double-stranded RNA, the specific proteins of these 
DAI, IFI16, and DDX41 receptors induce the production of IFN and inflamasome 
and, in turn, the production of IL-1β and IL-18.
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